Secondary Logo

Journal Logo

Most Popular Articles

Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products

Kogan, Alexander E.; Mukharyamova, Kadriya S.; Bereznikova, Anastasia V.; More

Blood Coagulation & Fibrinolysis. 27(5):542-550, July 2016.

Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study)

Lissitchkov, Toshko J.; Buevich, Evgeny; Kuliczkowski, Kazimierz; More

Blood Coagulation & Fibrinolysis. 28(2):152-162, March 2017.

Home treatment of haemarthrosis with recombinant activated factor VII in patients with haemophilia A or B and inhibitors: experience from developing countries

Bensadok, Meriem; Almomen, Abdulkareem; Alzoebie, Azzam; More

Blood Coagulation & Fibrinolysis. 28(2):145-151, March 2017.

Lack of grading agreement among international hemostasis external quality assessment programs

Olson, John D.; Jennings, Ian; Meijer, Piet; More

Blood Coagulation & Fibrinolysis. 29(1):111-119, January 2018.

Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass

Percy, Charles L.; Hartmann, Rudolf; Jones, Rhidian M.; More

Blood Coagulation & Fibrinolysis. 26(4):357-367, June 2015.

The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial

Lentz, Steven R.; Rangarajan, Savita; Karim, Faraizah A.; More

Blood Coagulation & Fibrinolysis. 28(3):224-229, April 2017.

Low-dose, short course alteplase treatment of submassive pulmonary embolism: a case series from the National Institutes of Health Clinical Center

Lozier, Jay N.; Elinoff, Jason M.; Suffredini, Anthony F.; More

Blood Coagulation & Fibrinolysis. 29(8):701-707, December 2018.

Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports

Wang, Michael; Álvarez-Román, María Teresa; Chowdary, Pratima; More

Blood Coagulation & Fibrinolysis. 27(7):737-744, October 2016.

Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study

Pernod, Gilles; Wu, Haifeng; de Maistre, Emmanuel; More

Blood Coagulation & Fibrinolysis. 28(3):254-260, April 2017.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study

Aguilar, Carlos; Sartori, Michelangelo; D’Angelo, Armando; More

Blood Coagulation & Fibrinolysis. 29(6):562-566, September 2018.

Thromboelastographic study of the snakebite-related coagulopathy in Djibouti

Larréché, Sébastien; Jean, François-Xavier; Benois, Alain; More

Blood Coagulation & Fibrinolysis. 29(2):196-204, March 2018.

Two novel cases of cerebral haemorrhages at the neonatal period associated with inherited factor VII deficiency, one of them revealing a new nonsense mutation (Ser52Stop)

Giansily-Blaizot, Muriel; Aguilar-Martinez, Patricia; Briquel, Marie-Elisabeth; More

Blood Coagulation & Fibrinolysis. 14(2):217-220, February 2003.

Show: